Rare spinal hemangiosarcoma case highlights MRI-CT staging in a dog
Bottom line
Version 1
An April 2026 case report in Veterinary Radiology & Ultrasound describes an 8-year-old neutered male Australian Shepherd with acute lumbosacral pain that was ultimately diagnosed with an extradural-extramedullary lumbar hemangiosarcoma, an exceptionally rare spinal presentation in dogs. MRI identified a well-demarcated mass spanning L6 to L7 and compressing the conus medullaris, cauda equina, and left sciatic nerve roots; surgical decompression confirmed hemangiosarcoma on histopathology. Follow-up thoracic and abdominal CT then revealed pulmonary, hepatic, and subcutaneous lesions consistent with metastatic disease. The authors say this is only the second reported extradural-extramedullary lumbar hemangiosarcoma in a dog, and the first report to include complete metastatic staging with CT. (lifescience.net)
Why it matters: For veterinary professionals, the report is a reminder that hemangiosarcoma can appear in atypical spinal locations, even when initial signs center on pain and gait reluctance rather than collapse or hemoabdomen. It also highlights the value of pairing MRI for local lesion characterization with CT for staging, especially because pulmonary hemangiosarcoma metastases may show features such as small, well-defined nodules, a ground-glass halo, and feeding vessel signs that can help prioritize metastatic HSA on imaging. (lifescience.net)
What to watch: Whether this report changes how referral centers stage unusual spinal masses, particularly by prompting earlier whole-body CT in dogs with suspected vascular or sarcomatous lesions. (lifescience.net)
Version 2
A newly published case report in Veterinary Radiology & Ultrasound adds to the small body of literature on spinal hemangiosarcoma in dogs, detailing an 8-year-old Australian Shepherd with acute lumbosacral pain whose lumbar mass proved to be an extradural-extramedullary hemangiosarcoma. After MRI localized the lesion from L6 to L7 and surgery relieved compression, histopathology confirmed the diagnosis. Staging CT then identified pulmonary nodules with imaging features considered highly characteristic of metastatic hemangiosarcoma, along with hepatic and subcutaneous nodules. (lifescience.net)
What makes the report notable is just how uncommon this location appears to be. The authors describe it as only the second reported extradural-extramedullary lumbar hemangiosarcoma in a dog, building on a 2015 Journal of the American Animal Hospital Association case report that described a primary lumbar extradural hemangiosarcoma without evidence of metastasis during 15 months of follow-up after surgery and chemotherapy. Other published canine spinal HSA reports have involved different anatomic compartments, including intradural-extramedullary disease and other unusual spinal cord locations. (lifescience.net)
In the new case, MRI was central for defining the neurologic lesion: the mass was described as well-demarcated, left-lateralized, T1 hypointense, and homogeneously hyperintense on T2-weighted and STIR sequences, with partial contrast enhancement. It displaced and compressed the conus medullaris and cauda equina, including the left sciatic nerve roots, helping explain the dog’s acute pain and reluctance to walk. Surgery established the tissue diagnosis, but CT supplied the broader oncologic picture by identifying metastatic-pattern lung lesions as well as hepatic and subcutaneous nodules. (lifescience.net)
That staging component is one of the paper’s most practical contributions. Recent veterinary imaging work has found that pulmonary hemangiosarcoma metastases on CT are often generalized, small, well-defined nodules, frequently accompanied by a halo sign and feeding vessels. Those same features were reported in this dog, which strengthens the authors’ argument that multimodal imaging can do more than find a mass, it can help clinicians recognize a metastatic pattern before every lesion is sampled. Broader hemangiosarcoma reviews also support advanced imaging, including CT and MRI, for more accurate staging and treatment planning. (lifescience.net)
Direct outside commentary on this specific case was limited, but the wider oncology consensus is consistent: canine hemangiosarcoma is highly malignant, biologically aggressive, and often metastatic at diagnosis. Cornell’s canine health guidance similarly notes that staging commonly includes thoracic imaging and may include CT to assess spread, while oncology reviews emphasize that advanced imaging can refine case selection and clinical decision-making. In that context, this report is less about changing what clinicians know about HSA biology and more about sharpening recognition of an uncommon presentation. (vet.cornell.edu)
Why it matters: For general practitioners, neurologists, surgeons, radiologists, and oncologists, the case widens the differential list for acute lumbosacral pain and compressive lumbar lesions. Hemangiosarcoma may not be top of mind for an extradural-extramedullary spinal mass, particularly without an obvious visceral primary lesion at presentation. The report also reinforces a workflow point: MRI may be the best tool to characterize the spinal lesion and surgical anatomy, but CT can materially change prognosis discussions by revealing systemic spread that would otherwise be missed or underappreciated. (lifescience.net)
It also has communication value with pet parents. A dog that presents for pain, reluctance to walk, or neurologic deficits may still have a disease process with metastatic behavior more commonly associated with splenic or cardiac HSA. That makes early staging, realistic counseling, and coordinated referral especially important when histopathology identifies a vascular sarcoma in an unusual site. (lifescience.net)
What to watch: Case reports won’t settle prognosis or best treatment for this rare spinal presentation, but they can shape referral habits. The next thing to watch is whether more centers report similar cases and whether whole-body CT becomes a more routine part of staging for dogs with atypical spinal sarcomas or suspected vascular tumors. (lifescience.net)